MAIA Biotechnology, Inc. (MAIA)Healthcare | Biotechnology | Chicago, United States | NYSE American
1.32 USD
-0.09
(-6.383%) ⇩
(April 21, 2026, 4 p.m.
EDT)
After hours: 1.34 +0.02 (1.515%) ⇧ (April 21, 2026, 4:56 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:35 p.m. EDT
MAIA remains a high-risk binary play on a pivotal Phase 3 trial, with its recent $33M capital raise stabilizing operations but leaving the stock range-bound below both 50-day and 200-day moving averages, while the AI forecast explicitly predicts downside pressure over the next 45 days. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.253314 |
| AutoETS | 0.258899 |
| MSTL | 0.261197 |
| AutoARIMA | 0.275421 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 45% |
| H-stat | 8.58 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.288 |
| Excess Kurtosis | -0.98 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 80,086,376 |
| Forward P/E | 0.49 |
| Beta | 0.32 |
| Website | https://maiabiotech.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.24598932 |
| Address1 | 444 West Lake Street |
| Address2 | Suite 1700 |
| All Time High | 9.64 |
| All Time Low | 0.82 |
| Ask | 1.33 |
| Ask Size | 900 |
| Average Daily Volume10 Day | 806,540 |
| Average Daily Volume3 Month | 1,020,719 |
| Average Volume | 1,020,719 |
| Average Volume10Days | 806,540 |
| Beta | 0.316 |
| Bid | 1.32 |
| Bid Size | 1,000 |
| Book Value | 0.062 |
| City | Chicago |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.32 |
| Current Ratio | 1.662 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.42 |
| Day Low | 1.32 |
| Display Name | MAIA Biotechnology |
| Earnings Timestamp End | 1,754,683,200 |
| Earnings Timestamp Start | 1,754,683,200 |
| Ebitda Margins | 0.0 |
| Enterprise Value | 76,888,768 |
| Eps Current Year | -0.69 |
| Eps Forward | 2.7 |
| Eps Trailing Twelve Months | -0.7 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.6262 |
| Fifty Day Average Change | -0.3061999 |
| Fifty Day Average Change Percent | -0.18829167 |
| Fifty Two Week Change Percent | -24.598932 |
| Fifty Two Week High | 3.19 |
| Fifty Two Week High Change | -1.87 |
| Fifty Two Week High Change Percent | -0.5862069 |
| Fifty Two Week Low | 0.87 |
| Fifty Two Week Low Change | 0.45000005 |
| Fifty Two Week Low Change Percent | 0.5172414 |
| Fifty Two Week Range | 0.87 - 3.19 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,659,015,000,000 |
| Float Shares | 55,623,016 |
| Forward Eps | 2.7 |
| Forward P E | 0.4888889 |
| Free Cashflow | -11,023,186 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 13 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.12093 |
| Held Percent Institutions | 0.041479997 |
| Implied Shares Outstanding | 60,671,492 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois. |
| Long Name | MAIA Biotechnology, Inc. |
| Market | us_market |
| Market Cap | 80,086,376 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_631239285 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -22,396,172 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 85,546,802 |
| Number Of Analyst Opinions | 2 |
| Open | 1.44 |
| Operating Cashflow | -18,844,598 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 312 416 8592 |
| Post Market Change | 0.01999998 |
| Post Market Change Percent | 1.51515 |
| Post Market Price | 1.34 |
| Post Market Time | 1,776,804,965 |
| Previous Close | 1.41 |
| Price Eps Current Year | -1.9130436 |
| Price Hint | 4 |
| Price To Book | 21.290323 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.483 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0899999 |
| Regular Market Change Percent | -6.38297 |
| Regular Market Day High | 1.42 |
| Regular Market Day Low | 1.32 |
| Regular Market Day Range | 1.32 - 1.42 |
| Regular Market Open | 1.44 |
| Regular Market Previous Close | 1.41 |
| Regular Market Price | 1.32 |
| Regular Market Time | 1,776,801,600 |
| Regular Market Volume | 353,850 |
| Return On Assets | -1.5275501 |
| Return On Equity | -7.4523497 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 60,671,491 |
| Shares Percent Shares Out | 0.038 |
| Shares Short | 2,304,530 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 2,460,745 |
| Short Name | MAIA Biotechnology, Inc. |
| Short Percent Of Float | 0.041100003 |
| Short Ratio | 1.86 |
| Source Interval | 15 |
| State | IL |
| Symbol | MAIA |
| Target High Price | 14.0 |
| Target Low Price | 10.27 |
| Target Mean Price | 12.135 |
| Target Median Price | 12.135 |
| Total Cash | 8,658,031 |
| Total Cash Per Share | 0.143 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.7 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.56926 |
| Two Hundred Day Average Change | -0.24925995 |
| Two Hundred Day Average Change Percent | -0.15883917 |
| Type Disp | Equity |
| Volume | 353,850 |
| Website | https://maiabiotech.com |
| Zip | 60,606 |